SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
Roche at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Roche brings 1 presentation to SITC 2026 in Phoenix. Its program centres on industry strategy for cancer drug development. Roche sets out its approach to advancing oncology, drawing on a portfolio that spans bispecific antibodies and the PD-L1 drug atezolizumab.
| Organization | SITC 2026 Attendance |
|---|---|
Roche Basel, Switzerland | |
Swiss pharmaceutical and diagnostics company whose oncology portfolio includes the PD-L1 antibody atezolizumab and bispecific antibodies. | Talk Thu Nov 5 6:00pm–6:20pm Session Thu Nov 5 6:45pm–7:20pm |
Find decision makers at Roche
Tell us what you sell and we’ll find the people at Roche most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction